Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
about
The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptorsImmunoregulatory functions of immune complexes in vaccine and therapyTargeting dendritic cells: a promising strategy to improve vaccine effectivenessOrigin, Localization, and Immunoregulatory Properties of Pulmonary Phagocytes in Allergic AsthmaDirect Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesTowards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesTargeting C-Type Lectin Receptors for Cancer ImmunityCross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsPolarizing T and B Cell Responses by APC-Targeted Subunit VaccinesInvestigating Evolutionary Conservation of Dendritic Cell Subset Identity and FunctionsThe antigen presenting cells instruct plasma cell differentiationInnate and adaptive immune cells in the tumor microenvironmentSensing of cell death by myeloid C-type lectin receptorsDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine modelsMessenger RNA-based vaccines: progress, challenges, applicationsPros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesAntitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentationDendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytesMouse Conventional Dendritic Cells Can be Universally Classified Based on the Mutually Exclusive Expression of XCR1 and SIRPαThe chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cellsThe dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed settingA pH- and ionic strength-dependent conformational change in the neck region regulates DNGR-1 function in dendritic cells.HDAC6 regulates the dynamics of lytic granules in cytotoxic T lymphocytes.Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy.Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells.4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccinesHuman CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cellsCharacterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells.Dendritic cells in systemic lupus erythematosusOntogenic, Phenotypic, and Functional Characterization of XCR1(+) Dendritic Cells Leads to a Consistent Classification of Intestinal Dendritic Cells Based on the Expression of XCR1 and SIRPαBridging innate and adaptive antitumor immunity targeting glycans.Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice.Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIRDesigning vaccines based on biology of human dendritic cell subsetsDendritic cell maturation: functional specialization through signaling specificity and transcriptional programmingHuman macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.Dendritic-cell-based therapeutic cancer vaccines
P2860
Q24654154-8BB11A6F-4566-42D6-BEC0-5175C891A377Q26738396-4F6D1F57-47DF-4AE1-A6B5-E00299EE883FQ26746162-97BF8997-496A-4505-A452-A1F3784A4E2CQ26752279-D1E2B621-7569-44AA-AD3F-03C003258D60Q26752558-B6E20B42-BD0D-4228-ACAA-F2C9CFA2542BQ26773073-DDDD034E-5FD4-43B0-BA2F-59AB16B876A5Q26784483-B2503CFA-EABD-42D5-B6C3-81C0D9C4BA54Q26799991-E2E7025F-B31E-40EE-A7FB-2CF26B18DB65Q26800145-7011401B-D64D-4974-92A3-A33BF1018CDCQ26995456-4BB85D8B-54B9-42E7-827B-F9F8AFFF932AQ26995780-119624AE-B9FF-4558-80E1-B9A1BC763ADCQ27008342-961B56C7-8D39-4F8E-9B03-1078ED175351Q27010313-941BD20F-3F79-4793-883C-B7C18A78EC9AQ27012618-84360AFF-04C7-413E-9E88-854E8C5D34A7Q27012738-6AD48866-8978-4752-AAE8-0743B3AADB23Q27013679-8E2A7E6F-A85A-4B32-8E5B-A592A31CA39AQ27026193-B301C167-B620-49DB-ABE3-DBB1084F04E9Q27310806-EEFA0458-7A30-4707-ACD0-0706DC8DFE19Q28084718-18B09838-71BA-4329-AC25-F14ED9661426Q28508363-8C37357B-8EF7-4F85-9745-351686DA8CFDQ29618424-45877190-4CB0-4EA2-9340-6F9EEECF00CFQ30394228-27511370-EC1F-4C7E-814B-9F7163868B9CQ30811074-6F4D37E1-0C38-462F-B152-55F89ACFA934Q33659782-6E1434FE-3D22-490E-B9F5-A00381C40825Q33814171-A921725F-0EBB-4AD4-985E-93A3AB3BBEB7Q33857971-0D378973-0F51-4CAE-BBC3-08C6262D2274Q33902330-6F8CB22B-ECFC-4CCA-AC53-F718B4A83AA9Q33902379-8A051A0D-4620-42BA-B383-5B270486F1EAQ33902421-E9F77D09-D5AC-4F6D-926F-AC1FD5849E67Q33941433-117875EE-2C12-47D8-9628-623D2DCC37EBQ33958439-B6DA4A05-D21F-4F0F-A656-D4CB90E54233Q33960021-5B374578-6AEE-4BF2-BEDB-69C598CE5E19Q34090836-7DEB9C41-D546-41B1-92EB-0FBA33122CA3Q34163004-E1D9412C-FD96-49C9-A0D5-B484A4B2F175Q34289152-5988D262-5BF1-4E4B-B2DC-4361C86F99D4Q34323795-88A70CF6-566F-4EDD-9D52-0203FA45578AQ34329143-771EB8DC-93A4-4442-BAD5-C8681D9DBFB4Q34341859-CB09A8E3-0042-47A1-8E26-69DACFFDC6CFQ34342500-F14579D5-7E54-457F-BDD2-A8DEA437CA96Q34360094-49041B08-FF2C-4BDA-9491-361E839F9AE0
P2860
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@ast
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en-gb
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@nl
type
label
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@ast
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en-gb
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@nl
prefLabel
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@ast
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en-gb
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@nl
P2093
P2860
P921
P3181
P356
P1476
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
@en
P2093
Daniel J Pennington
David Sancho
Diego Mourão-Sá
James R Carlyle
Neil C Rogers
Oliver Schulz
P2860
P304
P3181
P356
10.1172/JCI34584
P407
P577
2008-06-01T00:00:00Z